Glenmark Pharmaceuticals to meet investors in September 2025

Glenmark Pharmaceuticals Limited announced a schedule of analyst and institutional investor meetings for September 2025. The company will participate in three physical meetings, all held in Mumbai.

The schedule includes the Elara Investor Conference 2025 on September 3, 2025, and the Kotak Healthcare Forum 2025 on September 18, 2025. Both events are designated for group and one-on-one interactions. The final meeting is the DAM Capital Pharmaceutical Conference 2025 on September 23, 2025, also categorized for both interaction types.

Glenmark Pharmaceuticals confirmed that no unpublished price sensitive information will be disclosed during these meetings. The company also noted that the scheduled meetings are subject to change.